Wegovy and Teeth Issues: What Does the Evidence Actually Say?

No direct causal link between semaglutide and tooth decay has been identified in clinical trial data or current MHRA safety communications.
Frequent nausea and vomiting can introduce stomach acid into the mouth, which is a recognised risk factor for enamel erosion over time.
Dry mouth, reduced saliva production and changes in eating patterns on Wegovy may all have secondary effects on oral health that are worth discussing with your dentist.
If you experience persistent dental symptoms while on any GLP-1 medicine, report them via the MHRA Yellow Card scheme, patient reports directly shape what regulators investigate next.

There is no established clinical evidence that Wegovy directly damages teeth. What the evidence does show is that certain side effects of semaglutide — particularly nausea, vomiting and acid reflux — can affect oral health indirectly, and understanding that distinction matters if you are concerned. Wegovy is a prescription-only medicine; a GPhC-registered prescriber assesses your full health picture before it is dispensed.

Starting from £29.99/mo

Free 2-minute consultation · Reviewed same day

Start journey
The nume Promise

Order by 12pm.

At your door the next working day.
Free, tracked, plain packaging.

Guaranteed on approved orders

Where are you starting from?

BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.

Check your BMI.

Ten seconds. Private — nothing is stored or shared.

80 kg
170 cm

Your result updates live in the card alongside.

Your result

Your BMI is

which is in the healthy weight range

Start journey

BMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.

Treatment options

Weight loss treatments

The problem

Most weight loss services treat you like a transaction, a checkout, a courier, and you're on your own.

Algorithm approvalsNo real clinicianGeneric dosingHidden feesSlow deliverySilence after checkout

The nume way

We built the opposite: one clinician who knows you, guaranteed care at every step.

24 hrs

clinician review. Free next working day delivery.

How it works

From consultation to your door, properly.

Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.

Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.

Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.

The Connection Between Semaglutide, GI Side Effects and Oral Health

What the clinical trial data tells us about GI effects and the mouth

The STEP 1 trial, published in the New England Journal of Medicine, reported that gastrointestinal side effects affected a substantial proportion of participants on semaglutide 2.4mg, nausea, vomiting and reflux being the most common. These findings are consistent with what the NHS semaglutide medicines page lists as known side effects. If you want to understand more about how these effects can reach the mouth, our page on what semaglutide can mean for your teeth walks through the biology in plain terms.

Stomach acid has a pH well below what tooth enamel can comfortably tolerate. If vomiting or acid reflux is frequent enough (especially in the first weeks of treatment or after a dose increase) enamel can begin to soften and wear. This is not a Wegovy-specific phenomenon; it applies to anyone who experiences regular acid exposure in the mouth. The medicine is the indirect cause, the acid is the direct one.

The available evidence does not support the idea that semaglutide has a direct pharmacological effect on teeth or gums. What it does support is that managing GI side effects well, particularly nausea and vomiting, protects more than just your comfort.

Dry mouth, reduced appetite and what they mean for dental health

Saliva is an underrated player in oral health. It neutralises acids, washes away food debris and delivers minerals that help remineralise enamel. Some people on GLP-1 medicines including Wegovy report a dry mouth, and a significant reduction in appetite often means eating less frequently. Both can reduce saliva flow below its usual baseline.

Reduced eating frequency is not inherently bad for teeth, fewer sugar exposures per day is textbook dentistry. But if the overall fluid and food intake drops too far, or if someone is not drinking enough water alongside treatment, the protective effect of saliva diminishes. Our overview of common semaglutide concerns covers hydration and nutrition in more detail, because they affect more than just dental health on this treatment.

Changes in diet composition also matter. A reduced-calorie eating pattern alongside Wegovy is part of the licensed indication; if that pattern becomes very low in calcium or nutrients relevant to bone density, there may be downstream effects on jawbone and tooth support over time, though this remains more theoretical than evidenced in current published trial data.

Practical steps that actually help if you're concerned about your teeth

Dentists already have established guidance for patients who experience acid reflux or regular vomiting from any cause, and those recommendations apply here. Rinsing with plain water or a fluoride mouthwash after vomiting or reflux episodes is helpful; brushing immediately afterwards is not, because softened enamel is more vulnerable to abrasion in the short term. Waiting around 30 minutes before brushing is the standard advice from dental professionals.

Telling your dentist you are on Wegovy is worth doing at your next routine appointment. They can assess your enamel, check for acid erosion patterns and adjust their advice to your individual situation. If you are noticing tooth sensitivity or pain specifically, the details on Wegovy and tooth pain cover that more closely, including when symptoms warrant prompt attention rather than a routine check.

Staying well-hydrated, choosing water or milk over acidic drinks, and maintaining a regular oral hygiene routine are straightforward habits. None of them require stopping treatment; they sit alongside it. If GI symptoms are severe enough to feel unmanageable, that is a conversation for your prescriber, not a reason to quietly push through.

When to flag dental concerns to a clinician

Occasional mild nausea that settles within a few days of a dose change is expected and documented. Persistent vomiting (the kind that happens daily or disrupts normal life) is not something to normalise, and it carries a higher risk of acid damage to teeth as well as dehydration, so our page covering the broader issues people encounter with Wegovy is worth reading if you are unsure what falls within normal range. The NHS England weight management injections guidance is clear that ongoing unmanageable side effects should be reviewed by a prescriber.

Severe or sudden dental symptoms, including significant pain or loose teeth, are unlikely to be connected to Wegovy but should still be assessed by a dentist promptly on their own merits. If you are on Wegovy through nume and have a clinical concern between your regular reviews, our aftercare team is available seven days a week. Questions about what is and is not expected from treatment are exactly what that support exists for. You can also look through our frequently asked questions or read more broadly about how semaglutide works in the body, which gives useful context for why GI effects happen at all.

For anyone thinking about starting Wegovy or transferring from another provider, our prescribers review every consultation personally. If you have also noticed changes to your cycle since starting treatment, our dedicated page on Wegovy and period changes covers what is known about that and when to seek advice. Your pen would arrive by tracked DPD in plain packaging, the clinical assessment happens long before it lands on the doorstep. Speak to our prescribers if you want to understand whether Wegovy is clinically suitable for you.

Looking to start your weight loss journey?
Take a quick eligibility quiz to explore your options and see how we can support you.
Start free consultation

The people

Meet the team.

Mahommed Zunaid Ayub Patel

Superintendent Pharmacist (GPhC No. 2217101)

Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.

Mostafa Damghani

Clinical Lead (GPhC No. 2231744)

Sets our clinical standards and checks everything we publish against current MHRA guidance.

Shelan Salih

Independent Prescriber (GPhC No. 2084501)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Rehenaaz Uddin

Independent Prescriber (GPhC No. 2083426)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Frequently asked questions